Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial

The Lancet Digital Health - Tập 5 - Trang e607-e617 - 2023
Peter G Jacobs1, Navid Resalat1, Wade Hilts1, Gavin M Young1, Joseph Leitschuh1, Joseph Pinsonault1, Joseph El Youssef2, Deborah Branigan2, Virginia Gabo2, Jae Eom2, Katrina Ramsey3, Robert Dodier1, Clara Mosquera-Lopez1, Leah M Wilson2, Jessica R Castle2
1Artificial Intelligence for Medical Systems Lab, Department of Biomedical Engineering, Center for Health and Healing, Oregon Health and Science University, Portland, OR, USA
2Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, OR, USA
3Oregon Clinical and Translational Research Institute Biostatistics and Design Program, Oregon Health and Science University, Portland, OR, USA

Tài liệu tham khảo

Bergenstal, 2016, Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes, JAMA, 316, 1407, 10.1001/jama.2016.11708 Brown, 2021, Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes, Diabetes Care, 44, 1630, 10.2337/dc21-0172 Brown, 2019, Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes, N Engl J Med, 381, 1707, 10.1056/NEJMoa1907863 Ware, 2022, Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial, Lancet Digit Health, 4, e245, 10.1016/S2589-7500(22)00020-6 Tsoukas, 2021, A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial, Lancet Digit Health, 3, e723, 10.1016/S2589-7500(21)00139-4 Wilson, 2022, Opportunities and challenges in closed-loop systems in type 1 diabetes, Lancet Diabetes Endocrinol, 10, 6, 10.1016/S2213-8587(21)00289-8 Moser, 2020, Diabetologia, 63, 2501, 10.1007/s00125-020-05263-9 Riddell, 2017, Exercise management in type 1 diabetes: a consensus statement, Lancet Diabetes Endocrinol, 5, 377, 10.1016/S2213-8587(17)30014-1 Yardley, 2013, Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes, Diabetes Care, 36, 537, 10.2337/dc12-0963 Tyler, 2022, Quantifying the impact of physical activity on future glucose trends using machine learning, iScience, 25, 1, 10.1016/j.isci.2022.103888 Paldus, 2022, A randomized crossover trial comparing glucose control during moderate-intensity, high-intensity, and resistance exercise with hybrid closed-loop insulin delivery while profiling potential additional signals in adults with type 1 diabetes, Diabetes Care, 45, 194, 10.2337/dc21-1593 Reddy, 2018, Accuracy of wrist-worn activity monitors during common daily physical activities and types of structured exercise: evaluation study, JMIR Mhealth Uhealth, 6, 10.2196/10338 Turksoy, 2018, Multivariable artificial pancreas for various exercise types and intensities, Diabetes Technol Ther, 20, 662, 10.1089/dia.2018.0072 DeBoer, 2017, Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D, Pediatr Diabetes, 18, 540, 10.1111/pedi.12454 Garcia-Tirado, 2021, Anticipation of historical exercise patterns by a novel artificial pancreas system reduces hypoglycemia during and after moderate-intensity physical activity in people with type 1 diabetes, Diabetes Technol Ther, 23, 277, 10.1089/dia.2020.0516 Jacobs, 2015, Incorporating an exercise detection, grading, and hormone dosing algorithm into the artificial pancreas using accelerometry and heart rate, J Diabetes Sci Technol, 9, 1175, 10.1177/1932296815609371 Wilson, 2020, Dual-hormone closed-loop system using a liquid stable glucagon formulation versus insulin-only closed-loop system compared with a predictive low glucose suspend system: an open-label, outpatient, single-center, crossover, randomized controlled trial, Diabetes Care, 43, 2721, 10.2337/dc19-2267 Resalat, 2016, Design of a dual-hormone model predictive control for artificial pancreas with exercise model, Ann Int Conf IEEE Eng Med Biol Soc, 2016, 2270 Resalat, 2017, Evaluation of model complexity in model predictive control within an exercise-enabled artificial pancreas, IFAC-PapersOnLine, 50, 7756, 10.1016/j.ifacol.2017.08.2270 Castle, 2018, Randomized outpatient trial of single and dual-hormone closed-loop systems that adapt to exercise using wearable sensors, Diabetes Care, 41, 1471, 10.2337/dc18-0228 Jacobs, 2016, Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy, Diabetes Obes Metab, 18, 1110, 10.1111/dom.12707 Hovorka, 2004, Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes, Physiol Meas, 25, 905, 10.1088/0967-3334/25/4/010 Wilinska, 2005, Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin, IEEE Trans Biomed Eng, 52, 3, 10.1109/TBME.2004.839639 Hernández-Ordoñez, 2008, An extension to the compartmental model of type 1 diabetic patients to reproduce exercise periods with glycogen depletion and replenishment, J biomechanics, 41, 744, 10.1016/j.jbiomech.2007.11.028 Jacobs, 2014, Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies, IEEE Trans Biomed Eng, 61, 2569, 10.1109/TBME.2014.2323248 Mosquera-Lopez, 2023, Incorporating glucose variability into glucose forecasting accuracy assessment using the new glucose variability impact index and the prediction consistency index: an LSTM case example, J Diabetes Sci Technol, 16, 7, 10.1177/19322968211042621 Resalat, 2019, A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model, PloS one, 14, 1, 10.1371/journal.pone.0217301 2022, 6. Glycemic targets: standards of medical care in diabetes—2022, Diabetes Care, 45, S83 Breton, 2017, Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study, Diabetes Care, 40, 1644, 10.2337/dc17-0883 Zaharieva, 2017, The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous versus circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion, Diabetes Technol Ther, 19, 370, 10.1089/dia.2017.0010 Yardley, 2022, Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity, Diabetologia, 65, 1994, 10.1007/s00125-022-05781-8 Riddell, 2023, Examining the acute glycemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting: the type 1 diabetes and exercise initiative (T1DEXI), Diabetes Care, 46, 704, 10.2337/dc22-1721